News & Updates

Adding percent free prostate-specific antigen (PSA) to total PSA results in better prediction of clinically significant prostate cancer and fatal prostate cancer in men, reports a study.

Genetic evidence confirms both the positive and negative associations of low-density lipoprotein cholesterol (LDL-C) reduction with certain metabolic and cardiovascular diseases (CVDs), according to the results of a Mendelian randomization (MR) study in the UK Biobank.

A spatio-temporal analysis by researchers from The Chinese University of Hong Kong finds significant associations between high ambient particulate matter (PM)_2.5 concentration and increased rates of pulmonary tuberculosis (TB) among the elderly.

In the first-line treatment of patients with advanced nonsmall cell lung cancer (NSCLC) harbouring EGFR mutation, the combination of osimertinib plus pemetrexed and platinum-based chemotherapy outperformed osimertinib alone in terms of extending progression-free survival (PFS), according to the interim results of the phase III FLAURA2 trial presented at WCLC 2023.

People who walk as few as approximately 2,500 and 2,700 steps per day appear to enjoy significantly lower risks of mortality and cardiovascular disease (CVD), with greater risk reductions seen when walking up to about 8,800 and 7,100 steps per day, respectively, suggests a study.